A QScience Movember: Prostate cancer research highlights

Movember is an annual month-long event which involves participants growing their mustaches to raise awareness of prostate cancer (and other male cancers/illnesses). According to Wikipedia (relax this is a blog post not an peer-reviewed academic paper), Movember aims to increase early cancer detection, diagnosis and efface treatments). I have had a fully grown mustache every since I moved back to Bahrain/Qatar, and I think it is somewhat futile to shave it and let it grow back this November (as it would only take 30 minutes to grow back, see YouTube video below). Instead, I thought  to highlight some of QScience.com‘s content on prostate cancer.

movember-blog-585

 

1. The following are five conference proceedings from the Qatar Foundation Annual Research Forum which have a direct focus on prostate cancer in the region as well as proposals for novel therapies.

Genome-wide association study of prostate cancer in Arab populations: Identification of three genomic regions with multiple consecutive prostate cancer susceptibility loci.  Shan et al., Qatar Foundation Annual Research Forum Proceedings: Vol. 2012, BMP71 Abstract

Personalized peptide-based vaccine design for prostate cancer immunotherapy. Arreadouani et al., Qatar Foundation Annual Research Forum Proceedings: Vol. 2012, AESNP13. Abstract

Biosensor to identify novel compounds with anti-prostate cancer activity.  Abou-Gharbia et al., Qatar Foundation Annual Research Forum Proceedings: Vol. 2012, AESNP8. Abstract

Identification of novel anti-apoptotic signals in prostate cancer stem cells.  Sastry et al., Qatar Foundation Annual Research Forum Proceedings: Vol. 2012, BMP55. Abstract

PCA3 molecular urine test: Development of an easy and cheap assay of a potential use in the diagnosis of prostate cancer.  Al-Rumaihi et., Qatar Foundation Annual Research Forum Proceedings: Vol. 2012, BMP80. Abstract

2. The following articles are from the Journal of Local and Global Health Science. Whereas, they do not solely focus on prostate cancer, they do discuss it in the context of circadian rhythm disruption and use of arsenic as a therapeutic agent:

The two opposite facets of arsenic: toxic and anticancer drug. Florea and Büsselberg. Journal of Local and Global Health Science,Volume 2013.3, 1 Abstract

Disruption of circadian rhythm increases the risk of cancer, metabolic syndrome and cardiovascular disease. Shanmugam et al., Journal of Local and Global Health Science,Volume 2013.3 Abstract 

Enjoy reading the articles! (and for those who are growing mustaches, good luck!)
Alwaleed Alkhaja

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s